시장보고서

상품코드

1552951

암배아항원 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 성별, 제품별, 검사별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Carcinoembryonic Antigen Market Size, Share & Trends Analysis Report By Type (Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer), By Gender, By Product, By Test, By End Use, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 90 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

암배아항원 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 전 세계 암배아항원 시장 규모는 2030년까지 29억 5,000만 달러에 달할 것이며, 2024년부터 2030년까지 연평균 5.5%의 CAGR로 성장할 것으로 성장할 것으로 예상됩니다.

다른 바이오마커와 함께 사용할 수 있는 새로운 바이오마커의 개발에 대한 끊임없는 기술 발전은 예측 기간 동안 바이오마커의 사용률을 증가시킬 것으로 예상됩니다. 또한, 세계보건기구(WHO)의 추정에 따르면 2012년 전 세계 암 환자 수는 약 1,410만 명이며, 이 중 여성 환자는 6.7백만 명, 남성 환자는 7.4백만 명으로, 암 유병률이 증가함에 따라 효과적인 진단 도구에 대한 수요가 증가할 것으로 예상됩니다. 최소침습적 진단법에 대한 수요 증가도 시장 성장을 결정하는 데 중요한 역할을 할 것으로 예상됩니다. 최소침습적 진단 기법과 관련된 주요 장점은 작은 절개창으로 인한 환자 만족도가 높다는 점입니다. 또한, 이러한 시술은 입원 기간이 상대적으로 짧기 때문에 경제적으로 실행 가능하며, 시술 후 합병증이 적습니다.

암배아항원 시장 보고서 하이라이트:

대장암은 2023년에 1억 9,332만 달러로 추정되는 대장암은 암배아항원 시장에서 가장 큰 수익을 창출하는 응용 분야 중 하나입니다. 대장암의 유병률 증가와 다양한 단계에서 암배아항원 검사의 사용은 큰 점유율을 차지하는 중요한 요인 중 하나입니다. 예를 들어, 2012년 미국에서만 93,000명 이상의 신규 대장암 환자가 발생했으며, 대장암으로 인한 사망자 수는 49,700명 이상으로 추산됩니다.
암배아항원을 기반으로 한 유방암 진단은 시장에서 가장 유리한 응용 분야로 인식되고 있습니다. 이 시장은 50세 이상의 여성 인구 증가, 호르몬 대체요법(HRT) 및 미용 성형 수술에 대한 수요 증가와 같은 요인에 의해 주도되고 있습니다. 또한, 환자의 인식 수준이 높아지고 정부의 유리한 이니셔티브가 존재함에 따라 예측 기간 동안 치료율이 향상될 것으로 예상됩니다.
북미는 높은 유병률, 유리한 상환 체계의 존재, 상대적으로 높은 의료비 수준과 함께 높은 소비자 인식 수준으로 인해 2023년 가장 큰 지역 시장으로 부상했습니다.
아시아태평양은 예측 기간 동안 가장 유리한 성장세를 보일 것으로 예상됩니다. 미개척 기회, 지속적인 의료 인프라 개선, 경제 발전, 환자 인식 수준 향상 등이 이 지역의 급격한 성장 요인으로 꼽힙니다.

암배아항원 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제10장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Quest Diagnostics Incorporated
- F. Hoffmann-La Roche Ltd
- Creative Diagnostics
- Aviva Systems Biology Corporation
- Abbott
- Laboratory Corporation of America Holdings
- Merck KGaA
- Omega Diagnostics Ltd
- Boster Biological Technology
- Lee BioSolutions

ksm 24.09.24

Carcinoembryonic Antigen Market Growth & Trends:

The global carcinoembryonic antigen market size is expected to reach USD 2.95 billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools. According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients. Increasing demand for minimally invasive diagnostics procedures is also expected to play a vital role in determining market growth. Key advantages associated with minimally invasive diagnostics procedures include elevated patient satisfaction levels as they entail minor incision wounds. In addition, these procedures involve relatively lesser hospital stays and therefore, are economically viable and involve fewer post procedure complications.

Carcinoembryonic Antigen Market Report Highlights:

Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 193.32 million in 2023. Increasing prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of the critical factors accounting for its large share. For instance, in 2012, new cases of colorectal cancer were estimated to be over 93,000 and death due to colorectal cancer is expected to be over 49,700 in the U.S alone.
Carcinoembryonic antigen based breast cancer diagnosis is identified as the most lucrative application segment of the market. The market is driven by factors such as growing number of female population above 50 years, growing demand for Hormone Replacement Therapy (HRT) and cosmetic surgeries. Moreover, growing patient awareness levels and the presence of favorable government initiatives are expected to improve treatment rates over the forecast period.
North America was the largest regional market in 2023 owing to, the presence of high incidence rates, presence of favorable reimbursement framework, and high consumer awareness levels coupled with relatively higher healthcare expenditure levels.
Asia Pacific is anticipated to witness the most lucrative growth over the forecast period. The presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and improving patient awareness levels are some factors accounting for this rapid growth.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Carcinoembryonic Antigen Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Carcinoembryonic Antigen Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Carcinoembryonic Antigen Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Carcinoembryonic Antigen Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Colorectal Cancer
- 4.3.1. Colorectal Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Pancreatic Cancer
- 4.4.1. Pancreatic Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Ovarian Cancer
- 4.5.1. Ovarian Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Breast Cancer
- 4.6.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Thyroid Cancer
- 4.7.1. Thyroid Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Others
- 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Carcinoembryonic Antigen Market: Gender Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Carcinoembryonic Antigen Market: Gender Movement Analysis, 2023 & 2030 (USD Million)
5.3. Male
- 5.3.1. Male Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Female
- 5.4.1. Female Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Carcinoembryonic Antigen Market: Product Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Carcinoembryonic Antigen Market: Product Movement Analysis, 2023 & 2030 (USD Million)
6.3. CD66a
- 6.3.1. CD66a Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. CD66b
- 6.4.1. CD66b Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. CD66c
- 6.5.1. CD66c Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. CD66d
- 6.6.1. CD66d Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. CD66f
- 6.7.1. CD66f Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Carcinoembryonic Antigen Market: Test Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Carcinoembryonic Antigen Market: Test Movement Analysis, 2023 & 2030 (USD Million)
7.3. Molecular Tests
- 7.3.1. Molecular Tests Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Serology Tests
- 7.4.1. Serology Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Carcinoembryonic Antigen Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Carcinoembryonic Antigen Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
8.3. Hospitals
- 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Laboratories
- 8.4.1. Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Others
- 8.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Carcinoembryonic Antigen Market: Regional Estimates & Trend Analysis

9.1. Carcinoembryonic Antigen Market Share, By Region, 2023 & 2030 (USD Million)
9.2. North America
- 9.2.1. North America Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.2. U.S.
  - 9.2.2.1. U.S. Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.3. Canada
  - 9.2.3.1. Canada Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.4. Mexico
  - 9.2.4.1. Mexico Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
- 9.3.1. Europe Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. UK
  - 9.3.2.1. UK Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.3. Germany
  - 9.3.3.1. Germany Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.4. France
  - 9.3.4.1. France Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.5. Italy
  - 9.3.5.1. Italy Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.6. Spain
  - 9.3.6.1. Spain Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.7. Denmark
  - 9.3.7.1. Denmark Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.8. Sweden
  - 9.3.8.1. Sweden Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.9. Norway
  - 9.3.9.1. Norway Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
- 9.4.1. Asia Pacific Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. China
  - 9.4.2.1. China Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Japan
  - 9.4.3.1. Japan Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. India
  - 9.4.4.1. India Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.5. South Korea
  - 9.4.5.1. South Korea Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.6. Australia
  - 9.4.6.1. Australia Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.7. Thailand
  - 9.4.7.1. Thailand Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
- 9.5.1. Latin America Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Brazil
  - 9.5.2.1. Brazil Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Argentina
  - 9.5.3.1. Argentina Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
- 9.6.1. Middle East and Africa Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. South Africa
  - 9.6.2.1. South Africa Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. Saudi Arabia
  - 9.6.3.1. Saudi Arabia Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. UAE
  - 9.6.4.1. UAE Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. Kuwait
  - 9.6.5.1. Kuwait Carcinoembryonic Antigen Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
- 10.4.1. Quest Diagnostics Incorporated
  - 10.4.1.1. Participant's Overview
  - 10.4.1.2. Financial Performance
  - 10.4.1.3. Product Benchmarking
  - 10.4.1.4. Recent Developments/ Strategic Initiatives
- 10.4.2. F. Hoffmann-La Roche Ltd
  - 10.4.2.1. Participant's Overview
  - 10.4.2.2. Financial Performance
  - 10.4.2.3. Product Benchmarking
  - 10.4.2.4. Recent Developments/ Strategic Initiatives
- 10.4.3. Creative Diagnostics
  - 10.4.3.1. Participant's Overview
  - 10.4.3.2. Financial Performance
  - 10.4.3.3. Product Benchmarking
  - 10.4.3.4. Recent Developments/ Strategic Initiatives
- 10.4.4. Aviva Systems Biology Corporation
  - 10.4.4.1. Participant's Overview
  - 10.4.4.2. Financial Performance
  - 10.4.4.3. Product Benchmarking
  - 10.4.4.4. Recent Developments/ Strategic Initiatives
- 10.4.5. Abbott
  - 10.4.5.1. Participant's Overview
  - 10.4.5.2. Financial Performance
  - 10.4.5.3. Product Benchmarking
  - 10.4.5.4. Recent Developments/ Strategic Initiatives
- 10.4.6. Laboratory Corporation of America Holdings
  - 10.4.6.1. Participant's Overview
  - 10.4.6.2. Financial Performance
  - 10.4.6.3. Product Benchmarking
  - 10.4.6.4. Recent Developments/ Strategic Initiatives
- 10.4.7. Merck KGaA
  - 10.4.7.1. Participant's Overview
  - 10.4.7.2. Financial Performance
  - 10.4.7.3. Product Benchmarking
  - 10.4.7.4. Recent Developments/ Strategic Initiatives
- 10.4.8. Omega Diagnostics Ltd
  - 10.4.8.1. Participant's Overview
  - 10.4.8.2. Financial Performance
  - 10.4.8.3. Product Benchmarking
  - 10.4.8.4. Recent Developments/ Strategic Initiatives
- 10.4.9. Boster Biological Technology
  - 10.4.9.1. Participant's Overview
  - 10.4.9.2. Financial Performance
  - 10.4.9.3. Product Benchmarking
  - 10.4.9.4. Recent Developments/ Strategic Initiatives
- 10.4.10. Lee BioSolutions
  - 10.4.10.1. Participant's Overview
  - 10.4.10.2. Financial Performance
  - 10.4.10.3. Product Benchmarking
  - 10.4.10.4. Recent Developments/ Strategic Initiatives

암배아항원 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 성별, 제품별, 검사별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Carcinoembryonic Antigen Market Size, Share & Trends Analysis Report By Type (Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer), By Gender, By Product, By Test, By End Use, By Region, And Segment Forecasts, 2024 - 2030

암배아항원 시장 성장 및 동향:

암배아항원 시장 보고서 하이라이트:

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 암배아항원 시장 변수, 동향, 범위

제4장 암배아항원 시장 : 유형별 추정·동향 분석

제5장 암배아항원 시장 : 성별 추정·동향 분석

제6장 암배아항원 시장 : 제품별 추정·동향 분석

제7장 암배아항원 시장 : 검사별 추정·동향 분석

제8장 암배아항원 시장 : 최종 용도별 추정·동향 분석

제9장 암배아항원 시장 : 지역별 추정·동향 분석